Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability

Published:2023-11-15 Issue:12 Volume:62 Page:1921-1930
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Backlund Ellen¹²,Grozman Vitali³⁴,Egyhazi Brage Suzanne²,Lewensohn Rolf²,Lindberg Karin¹²,Helgadottir Hildur¹²^ORCID

Affiliation:

1. Department of Oncology, Karolinska University Hospital, Stockholm, Sweden

2. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

3. Department of Diagnostic Radiology, Karolinska University Hospital, Sweden

4. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2280766

Reference37 articles.

1. Socialstyrelsen. Statistics on Cancer Incidence 2020 Socialstyrelsen: socialstyrelsen; 2021 [cited 2021 2021-12-15]. Available from: www.socialstyrelsen.se/statistik-och-data/statistik/statistikamnen/cancer/.

2. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

3. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

4. Radiation-induced tumor neoantigens: imaging and therapeutic implications;Corso CD;Am J Cancer Res,2011

5. Combination of immune checkpoint inhibitors with radiation therapy in cancer: A hammer breaking the wall of resistance

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP